FDA Clearance Tracker · P910056-S051
enVista Hydrophobic Acrylic Intraocular Lens
Last checked: Nov 20, 2026Latest source record: Aug 21, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Aug 21, 2023
Approved
Time to decision
216 days
Received Jan 17, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P910056-S051
- Device name
- enVista Hydrophobic Acrylic Intraocular Lens
- Applicant
- Bausch & Lomb, Inc.
- Applicant location
- Irvine, CA
- Received
- Jan 17, 2023
- Decided
- Aug 21, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P910056
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the introduction of the UV + Duo material across the entire enVista® IOL portfolio along with the additions to the model number configurations, introduction of two additional IOL models (the enVista® ASPIRE monofocal [EA] and the enVista® ASPIRE toric [ETA]), and the inclusion of the option to have an electronic Instructions for Use (eIFU).
Source documents
Other decisions for Bausch & Lomb, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens510(k)
K262941 · Decided Oct 16, 2026 · 56 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.